The Impact of Smoking on Clinical Outcomes after Percutaneous Coronary Intervention in Women Compared to Men

Table 2

Comparison of different variables between MACE and not-MACE groups.

	MACE (n = 130)	Not-MACE (n = 1669)		HR	95% CI for HR
					Lower	Upper
Age (months)	57.74 ± 10.90	60.33 ± 11.21	0.011	0.985	0.969	1.001	0.071
Gender (male)	81 (62.3%)	1020 (61.1%)	0.788	1.058	0.718	1.560	0.774
DM	44 (33.8%)	489 (29.3%)	0.274	1.431	0.967	2.118	0.073
HTN	73 (56.2%)	926 (55.5%)	0.882	1.290	0.882	1.884	0.189
HLP	62 (47.7%)	855 (51.2%)	0.437	0.742	0.508	1.085	0.124
Smoking	80 (61.5%)	767 (46.0%)	0.001	1.617	1.116	2.343	0.011

DM: diabetes mellitus, HTN: hypertension, HLP: hyperlipidemia, MACE: major adverse cardiac events, : extracted from t-test or chi-square test in univariate approach, HR: hazard ratio (adjusted), CI: confidence interval, n = number, HR: adjusted HR, and : extracted from multiple proportional hazard cox regression analysis. Bold values imply significant differences.